Bictegravir 1611493-60-7
Sharaxaada
Bictegravir waa sheeko cusub, horjooge awood leh ee HIV-1 isku-dhafka IC50 ee 7.5 nM.
In Vitro
Bictegravir (BIC) waxay joojisaa dhaqdhaqaaqa wareejinta xadhigga IC50 ee 7.5± 0.3 nM Marka loo eego ka-hortagga dhaqdhaqaaqa wareejinta xargaha, Bictegravir waa horjooge aad u daciif ah oo ah 3"Waxqabadka HIV-1 IN, oo leh IC50 ee 241±51 nM. Bictegravir waxay kor u qaadaysaa ururinta 2-LTR wareegyada ~ 5-laab marka loo eego kantaroolka la daweeyay ee jeesjeeska ah waxayna yaraynaysaa qadarka alaabta isdhexgalka dhabta ah ee unugyada cudurka qaba 100-laab. Bictegravir waxay si xoog leh u joojisaa ku-noqoshada HIV-1 ee labadaba unugyada MT-2 iyo MT-4 ee leh EC50s ee 1.5 iyo 2.4 nM, siday u kala horreeyaan. Bictegravir waxay soo bandhigtaa saameyn xoog leh oo fayruska ka hortagga ah labadaba CD4+ T lymphocytes iyo macrophages monocyte-ka-soo-baxa, oo leh EC50s ee 1.5±0.3 nM iyo 6.6±4.1 nM, siday u kala horreeyaan, kuwaas oo u dhigma qiyamka laga helay xariiqyada T-cell[1].
MCE si madaxbanaan uma aysan xaqiijin saxnaanta hababkan. Waxay yihiin tixraac kaliya.
Lambarka NCT | Kafiil | Xaalad | Taariikhda Bilawga | Marxaladda |
NCT03998176 | Jaamacadda Nebraska | Sayniska Gilead | HIV-1-cudurka | Oktoobar 9, 2019 | Wajiga 4 |
NCT03789968 | Thomas Jefferson University|Jaamacadda Maryland, College Park | Caafimaadka Jaamacadda Indiana | Xarunta Isbitaalka Brooklyn | Jaamacadda Illinois ee Chicago | HIV+AIDS | Sebtember 1, 2019 | |
NCT04249037 | Jaamacadda Colorado, Denver | Sayniska Gilead | HIV+AIDS | Maarso 1, 2020 | Aan lagu dabaqi karin |
NCT04132674 | Xarunta cudurada faafa ee Vancouver | Fayraska Immundeficiency Immundeficiency Infection | Isticmaalka Daroogada | November 26, 2018 | Wajiga 4 |
NCT04054089 | Cristina Mussini | Jaamacadda Modena iyo Reggio Emilia | Caabuqa HIV | Sebtembar 2019 | Wajiga 4 |
NCT04155554 | Azienda Ospedaliera Universitaria Senese|Jaamacadda Katooliga ee Qalbiga Xurmada leh|Ospedale Policlinico San Martino|Azienda Ospedaliera San Paolo|Ospedale Amedeo di Savoia | HIV-1-cudurka | Janaayo 29, 2020 | Wajiga 3 |
NCT02275065 | Sayniska Gilecaad | Caabuqa HIV-1 | Oktoobar 2014 | Wajiga 1 |
NCT03711253 | Jaamacadda Koonfurta California | Caabuqa HIV Ba'an | Oktoobar 14, 2019 | Wajiga 4 |
NCT02400307 | Sayniska Gilecaad | HIV | Abriil 17, 2015 | Wajiga 1 |
NCT03499483 | Caafimaadka Bulshada Fenway | Kahortagga HIV | Janaayo 24, 2019 | Wajiga 4 |
NCT03502005 | Kooxda Cilmi-baarista Midland, Inc. | Sayniska Gilead | Fayraska difaaca jirka aadanaha | Maarso 1, 2018 | Wajiga 4 |
Qaab dhismeedka kiimikada





Soo jeedin18Mashaariicda Qiimaynta Joogtada Tayada ee la ansixiyay4iyo6mashaariicda ayaa ku socda ansixinta.

Nidaamka maaraynta tayada sare ee caalamiga ah ayaa aasaas adag u dhigay iibka.

Kormeerka tayada wuxuu ku socdaa dhammaan wareegga nolosha ee alaabta si loo hubiyo tayada iyo saameynta daaweynta.

Kooxda Arrimaha Xeer-ilaalinta Xirfadlayaasha waxay taageertaa shuruudaha tayada inta lagu jiro codsiga iyo diiwaangelinta.


Khadka Baakadaha ee Countec ee Kuuriya


Khadka Baakadaha Dhalada leh ee Taiwan CVC


Taliyaaniga CAM Khadka Baakadaha

Jarmal Fette Machine Compacting

Japan Viswill Tablet Detector

Qolka Xakamaynta DCS

